First Clinical Trial Of Cannabis For PTSD in Veterans Is Now Complete

cli

After a decade of working on the first FDA-approved trial examining the effects of THC and CBD on the symptoms of PTSD in war veterans, a team of researchers has declared their clinical trial complete. The process, however, was not simple.

“We are proud to have persevered through these regulatory hurdles independently of hospitals, universities, or the VA system,” commented site principal investigator Dr. Sue Sisley in a press release.

The Multidisciplinary Association for Psychedelic Studies (MAPS) received approval from the U.S. Public Health Service to start the study back in 2014. Research began in January 2017 at Phoenix, Arizona’s Scottsdale Research Institute, and was slated to also take place at Johns Hopkins University, until the school dropped out of the experiment in March 2017.

Continue reading “First Clinical Trial Of Cannabis For PTSD in Veterans Is Now Complete”

Cannabis for Post-Traumatic Stress Disorder: A Neurobiological Approach to Treatment

GB_USA_16_0037

The endocannabinoid system is intricately involved in regulation of the neurobiological processes, which underlie the symptomatology of posttraumatic stress disorder (PTSD).

This article discusses the neurobiological underpinnings of PTSD and the use of cannabis for treating PTSD in the New Mexico Medical Cannabis Program.1

Continue reading “Cannabis for Post-Traumatic Stress Disorder: A Neurobiological Approach to Treatment”